Cochlear Limited (ASX:COH)
Australia
· Delayed Price · Currency is AUD 305.99
-7.30 (-2.33%)
Aug 14, 2025, 4:10 PM AEST
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 30, 2024, with 32.38% growth. This brings the company's revenue in the last twelve months to 2.31B, up 7.42% year-over-year. In the fiscal year ending June 30, 2024, Cochlear had annual revenue of 2.24B with 15.47% growth.
Revenue (ttm)
2.31B
Revenue Growth
+7.42%
P/S Ratio
8.67
Revenue / Employee
457.48K
Employees
5,097
Market Cap
20.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | 1.32B | -106.10M | -7.44% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 212.98M |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
| Regis Healthcare | 1.10B |
Cochlear News
- 4 weeks ago - Australia news live: Albanese in Chengdu for last leg of China visit; German backpacker leaves hospital after outback ordeal - The Guardian
- 4 weeks ago - Cochlear CEO calls for tax shake-up to boost R&D - The Australian Financial Review
- 5 weeks ago - Cochlear Launches World's First and Only Smart Cochlear Implant System - PRNewsWire
- 5 weeks ago - Cochlear takes fast lane as it brings new hearing device to Chinese market - South China Morning Post
- 2 months ago - ASX 200 LIVE: ASX pares gains; Cettire dives 25pc after reporting weak US demand - The Australian Financial Review
- 2 months ago - Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users - Business Wire
- 2 months ago - Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™ - PRNewsWire
- 2 months ago - Labor takes $27m stake in breakthrough eye biotech - The Australian Financial Review